Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolites

Published:2014-12 Issue: Volume:564 Page:244-253
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Preston Pugh C.,Pouncey Dakota L.,Hartman Jessica H.,Nshimiyimana Robert,Desrochers Linda P.,Goodwin Thomas E.,Boysen Gunnar,Miller Grover P.

Funder

University of Arkansas for Medical Sciences

National Heart, Lung, and Blood Institute

NIGMS

SouthWest Affiliate of the American Heart Association

NIH

Hendrix College Odyssey

U.S. National Science Foundation

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference43 articles.

1. Pharmacology and Management of the Vitamin K Antagonists

2. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man

3. Human P450 metabolism of warfarin

4. Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

5. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin [see comments]

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Modeling of Warfarin ІI – Model-Based Analysis of Warfarin Metabolites after Warfarin Administered Either Alone or Together with Fluconazole or Rifampin;Drug Metabolism and Disposition;2022-07-07

2. USF1 Transcriptionally Regulates UGT1A3 and Promotes Lung Adenocarcinoma Progression by Regulating Neurotrophin Signaling Pathway;Frontiers in Molecular Biosciences;2022-01-27

3. Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin;Frontiers in Pharmacology;2022-01-13

4. Warfarin Dosing and Outcomes in Chronic Kidney Disease: A Closer Look at Warfarin Disposition;Current Drug Metabolism;2019-09-24

5. Combination of hesperetin and platinum enhances anticancer effect on lung adenocarcinoma;Biomedicine & Pharmacotherapy;2019-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3